Alnylam vs. Ionis: Here's the Better Bad-News Buy

Alnylam and Ionis are two beaten-down biotech stocks that have experienced significant sell-offs, potentially making them attractive investment opportunities.

The article suggests that the sell-offs for both companies may be overdone, presenting a buying opportunity for investors.